Literature DB >> 21722901

The new joint EAS/ESC guidelines for the management of dyslipidaemias.

Alberico L Catapano1, John Chapman, Olov Wiklund, Marji-Riitta Taskinen.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21722901     DOI： 10.1016/j.atherosclerosis.2011.06.011

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  9 in total

1.  Observational study to evaluate the safety and efficacy of saroglitazar in Indian diabetic dyslipidemia patients.

Authors:  Sadanand R Shetty; Soumitra Kumar; R P Mathur; Kamal H Sharma; Ashok D Jaiswal
Journal:  Indian Heart J       Date:  2015-02-26

2.  Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.

Authors:  Raul D Santos; Frederick J Raal; Alberico L Catapano; Joseph L Witztum; Elisabeth Steinhagen-Thiessen; Sotirios Tsimikas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-01-22       Impact factor: 8.311

Review 3.  The genetics of familial hypercholesterolemia and emerging therapies.

Authors:  Anja Vogt
Journal:  Appl Clin Genet       Date:  2015-01-28

Review 4.  Monitoring of lipids, enzymes, and creatine kinase in patients on lipid-lowering drug therapy.

Authors:  Olov Wiklund; Carlo Pirazzi; Stefano Romeo
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

5.  Risk factors for cerebrovascular disease mortality among the elderly in Beijing: a competing risk analysis.

Authors:  Zhe Tang; Tao Zhou; Yanxia Luo; Changchun Xie; Da Huo; Lixin Tao; Lei Pan; Fei Sun; Huiping Zhu; Xinghua Yang; Wei Wang; Aoshuang Yan; Xia Li; Xiuhua Guo
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

6.  Risk factors of CVD mortality among the elderly in Beijing, 1992 - 2009: an 18-year cohort study.

Authors:  Tao Zhou; Xia Li; Zhe Tang; Changchun Xie; Lixin Tao; Lei Pan; Da Huo; Fei Sun; Yanxia Luo; Wei Wang; Aoshuang Yan; Xiuhua Guo
Journal:  Int J Environ Res Public Health       Date:  2014-02-21       Impact factor: 3.390

Review 7.  The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.

Authors:  Rebecca J Brown; David Araujo-Vilar; Pik To Cheung; David Dunger; Abhimanyu Garg; Michelle Jack; Lucy Mungai; Elif A Oral; Nivedita Patni; Kristina I Rother; Julia von Schnurbein; Ekaterina Sorkina; Takara Stanley; Corinne Vigouroux; Martin Wabitsch; Rachel Williams; Tohru Yorifuji
Journal:  J Clin Endocrinol Metab       Date:  2016-10-06       Impact factor: 5.958

8.  Use of Lipid-Lowering Medications and the Likelihood of Achieving Optimal LDL-Cholesterol Goals in Coronary Artery Disease Patients.

Authors:  Dean G Karalis; Brett Victor; Lilian Ahedor; Longjian Liu
Journal:  Cholesterol       Date:  2012-07-25

9.  Lipid levels and new-onset diabetes in a hypertensive population: the China Stroke Primary Prevention Trial.

Authors:  Leliang Li; Ping Li; Juan Yang; Xiao Huang; Huihui Bao; Chunyan Zhang; Yun Song; Min Zhao; Meng Ji; Yi Wang; Geng Qian; Genfu Tang; Shanqun Jiang; Qiang Dong; Yan Zhang; Jianping Li; Xiping Xu; Binyan Wang; Yong Huo; Xiaoshu Cheng
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.